POST Online Media Lite Edition


Pfizer appoints James C. Smith as director

Staff writer |
New York, USA - June 30, 2014, New York, USA - Pfizer, Inc. announced the election of James C. Smith to its board of directors.

Article continues below

Mr. Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.

Mr. Smith is the President and Chief Executive Officer of Thomson Reuters and serves on its Board of Directors. Prior to his appointment as CEO in January 2012, he held various leadership positions at Thomson Reuters, including CEO and Chief Operating Officer (COO) of Thomson Reuters Professional Division.

Prior to the acquisition of Reuters PLC by Thomson, Mr. Smith served as COO of Thomson and President and CEO of Thomson Learning's Academic and Reference Group.


Ichnos Sciences appoints Sonia Quaratino to board
Ichnos Sciences welcomes Eric Feldman as new chief medical officer
Capital One Financial appoints Christine Detrick to board
Bankers Insurance hires David A. Erwin as president and CEO
American Equity Investment Life Holding appoints Dewayne Lummus as SVP

What to read next

Hill & Smith Holdings appoints Mark Reckitt as director
Director M. Anthony Burns steps down from Pfizer
Pfizer elects George A. Lorch non-executive chairman